COSCIENS Biopharma Inc. Reports Second Quarter 2025
COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq, while retaining the Company’s listing on…
BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates
BiomX Inc Positive Phase 2 results for BX211 demonstrated >40% wound size reduction vs. placebo in diabetic foot…
Linklaters reports record revenue and profit in FY25 – Linklaters
Linklaters reports record revenue and profit in FY25 LinklatersLinklaters partners take home record £2.2mn Financial TimesLinklaters smashes £1 billion profit…